NVNOW Stock Price, Chart, Stats & News

enVVeno Medical Corporation
Save
73.65M
Market cap
–
Current P/E
–
Forward P/E
NVNOW chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -65.87% |
ROE | -60.88% |
D/E | 0.03x |
Interest coverage ratio | – |
NVNOW valuation
P/E | – |
P/S | – |
P/B | 0.23x |
P/CF | -0.40x |
P/FCF | -0.01x |
P/OCF | -0.40x |
PEG | -0.01x |
EV multiple | -0.13x |
About
enVVeno Medical Corporation is a medical device firm dedicated to developing advanced bioprosthetic, tissue-based solutions with the aim of elevating the standard of care for various venous diseases. Central to its product pipeline is the VenoValve, a surgical implant currently under development specifically designed to address profound chronic venous insufficiency affecting the deep veins. When surgically positioned within the femoral vein, this innovative device functions as a unidirectional valve, thereby effectively restoring optimal blood flow in the leg.
Similar securities
Based on sector and market capitalization
Report issue











